Matrix metalloproteinase inhibition delays wound healing and blocks the latent transforming growth factor-beta1-promoted myofibroblast formation and function.
The ability to regulate wound contraction is critical for wound healing as well as for pathological contractures. Matrix metalloproteinases (MMPs) have been demonstrated to be obligatory for normal wound healing. This study examined the effect that the broad-spectrum MMP inhibitor BB-94 has when applied topically to full-thickness skin excisional wounds in rats and its ability to inhibit the promotion of myofibroblast formation and function by the latent transforming-growth factor-beta1 (TGF-beta1). BB-94 delayed wound contraction, as well as all other associated aspects of wound healing examined, including myofibroblast formation, stromal cell proliferation, blood vessel formation, and epithelial wound coverage. Interestingly, BB-94 dramatically increased the level of latent and active MMP-9. The increased levels of active MMP-9 may eventually overcome the ability of BB-94 to inhibit this MMP and may explain why wound contraction and other associated events of wound healing were only delayed and not completely inhibited. BB-94 was also found to inhibit the ability of latent TGF-beta1 to promote the formation and function of myofibroblasts. These results suggest that BB-94 could delay wound closure through a twofold mechanism; by blocking keratinocyte migration and thereby blocking the necessary keratinocyte-fibroblast interactions needed for myofibroblast formation and by inhibiting the activation of latent TGF-beta1.
Mirastschijski
Ursula
U
Department of Plastic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.
Schnabel
Reinhild
R
Claes
Juliane
J
Schneider
Wolfgang
W
Agren
Magnus S
MS
Haaksma
Carol
C
Tomasek
James J
JJ
D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects; D020780:Matrix Metalloproteinase 9 / Q000187:drug effects; D018919:Neovascularization, Physiologic / Q000187:drug effects; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology*; D051381:Rats; D012867:Skin / Q000166:cytology*; D017154:Stromal Cells / Q000187:drug effects / Q000378:metabolism; D013876:Thiophenes / Q000494:pharmacology*; D053773:Transforming Growth Factor beta1 / Q000037:antagonists & inhibitors; D014945:Wound Healing / Q000187:drug effects* / Q000502:physiology*
D011480:Protease Inhibitors; D013876:Thiophenes; D053773:Transforming Growth Factor beta1; D010649:Phenylalanine; C080985:batimastat; D020780:Matrix Metalloproteinase 9
J Invest Dermatol. 2002 Jan;118(1):55-64
11851876
J Am Podiatr Med Assoc. 2009 Nov-Dec;99(6):489-96
19917734
J Biol Chem. 2002 Jan 18;277(3):2065-72
11689563
Nature. 2008 May 15;453(7193):314-21
18480812
Exp Cell Res. 2000 May 25;257(1):180-9
10854066
Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1503-9
16690877
Proc Natl Acad Sci U S A. 1989 Sep;86(18):7285-9
2674952
Genes Dev. 2000 Jan 15;14(2):163-76
10652271
Lab Invest. 1990 Jul;63(1):21-9
2197503
J Invest Dermatol. 1994 Oct;103(4):554-9
7930681
EMBO J. 1999 Sep 1;18(17):4645-56
10469644
Matrix Biol. 2009 Mar;28(2):65-73
19379668
Am J Pathol. 2001 Oct;159(4):1555-66
11583981
Am J Physiol Lung Cell Mol Physiol. 2009 Feb;296(2):L236-47
19060229
Cancer Res. 2001 Feb 15;61(4):1272-5
11245418
Int J Biochem Cell Biol. 2008;40(6-7):1334-47
18083622
Exp Dermatol. 2001 Oct;10(5):337-48
11589731
Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1104-10
12601036
FEBS Lett. 1998 Dec 11;441(1):137-40
9877181
J Investig Dermatol Symp Proc. 2009 Aug;14(1):20-4
19675548
Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33
17318226
Curr Opin Cell Biol. 2004 Feb;16(1):14-23
15037300
Br J Surg. 1998 Jan;85(1):68-71
9462387
Am J Pathol. 2001 Sep;159(3):1009-20
11549593
Cell Mol Life Sci. 2009 Jan;66(2):203-24
18810321
EMBO J. 2005 Oct 5;24(19):3400-10
16148944
J Biol Chem. 2002 Nov 15;277(46):44061-7
12226090
Am J Pathol. 2004 Jun;164(6):2055-66
15161640
J Invest Dermatol. 2000 Aug;115(2):213-8
10951238
Matrix Biol. 2006 Oct;25(8):505-14
17010584
Exp Cell Res. 2002 Apr 15;275(1):110-21
11925109
J Invest Surg. 2002 Jul-Aug;15(4):199-207
12217184
Exp Cell Res. 1998 Jul 10;242(1):201-10
9665817
J Cell Biol. 1993 Jul;122(1):103-11
8314838
Biochim Biophys Acta. 2010 Jan;1803(1):39-54
19800373
Bioorg Med Chem. 2008 Oct 1;16(19):8781-94
18790648
Nat Rev Mol Cell Biol. 2002 May;3(5):349-63
11988769
Arch Dermatol Res. 1999 Nov;291(11):583-90
10638331
J Cell Biol. 2002 Apr 29;157(3):493-507
11970960
Ann Surg. 1999 Aug;230(2):260-5
10450741
Arch Otolaryngol Head Neck Surg. 2003 Feb;129(2):197-200
12578448
Am J Pathol. 2009 Aug;175(2):533-46
19590036
Exp Cell Res. 2004 Oct 1;299(2):465-75
15350544
Plast Reconstr Surg. 2000 Feb;105(2):638-47
10697171